Differentiation induction as a treatment for hematologic malignancies
Open Access
- 13 May 2002
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 21 (21) , 3496-3506
- https://doi.org/10.1038/sj.onc.1205328
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Translating the Histone CodeScience, 2001
- In vivo Effects of a Histone Deacetylase Inhibitor, FK228, on Human Acute Promyelocytic Leukemia in NOD/Shi‐scid/scid MiceJapanese Journal of Cancer Research, 2001
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- All- retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemiaSeminars in Hematology, 2001
- Reprogramming erythroleuekmia cells to terminal differentiation and terminal cell divisionFrontiers in Bioscience-Landmark, 2000
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998
- Induction of Differentiation of Human Myeloid Leukemia Cells by 2′-Deoxycoformycin in Combination with 2′-DeoxyadenosineBiochemical and Biophysical Research Communications, 1997
- Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cellsCell, 1994
- Clinical and prognostic significance of in vivo differentiation in acute myeloid leukemiaAmerican Journal of Hematology, 1993
- The nucleus: A black box being openedJournal of Cellular Biochemistry, 1991